0QOK (LSE) - Roche Holding AG Participation
Exchange: London Exchange • Country: UK • Currency: GBP • Type: Common Stock • ISIN: CH0012032048
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland. Web URL: https://www.roche.com
Drawdown (Underwater) Chart
External Links for 0QOK (LSE) - Roche Holding AG Participation
| Market Cap. | 301,216m GBP |
| TER | 0.00% |
| IPO / Inception |
Ratings
| Fundamental | - |
| Dividend | 3.97 |
| Performance 5y | 2.12 |
| Performance TTM | 2.11 |
| Relative Performance | -0.16 |
| Analysts | - |
| Price / Fair Price TR | 1.13 |
| Price / Fair Price DCF | todo |
Technical
| Growth TTM | -10.90% |
| CAGR 5y | 6.40% |
| CAGR / Mean Drawdown 5y | 0.67 |
| Sharpe Ratio TTM | -0.86 |
| Alpha vs SP500 TTM | -13.11 |
| Beta vs SP500 5y weekly | 0.36 |
| CAPM | 6.65% |
| Average Daily Range % | 1.42% |
| Volatility GJR Garch 1y | 17.11% |
| Max Drawdown 5y | 36% |
| Mean Drawdown 5y | 9.5% |
| Price / SMA 50 | 1.72% |
| Price / SMA 200 | -4.43% |
| Current Volume | 3.3k |
| Average Volume | 798.7k |
Dividends
| Rate TTM | 0.10 |
| Yield TTM | 0.00% |
| Div. CAGR 5y | 2.30% |
| Consistency of Dividends all time | 70.6% |